Search

The gut microbiome has been connected with human health and sickness, including all those affecting the brain, according to new evidence. Abnormalities in this microbiota-gut-brain axis have emerged as a significant component in the pathophysiology of depression, prompting exploratory research into the neuro-active potential of gut microbial metabolic products. Over the last decade, research has revealed a plethora of complicated interactions between the microbiota and the immunological and metabolic systems, many of which have important consequences for human health. Therefore in review, we emphasise accumulating evidence suggesting the microbiome exerts effect on the brain via multiple routes linking the stomach to the central nervous system. While knowledge of the influence of gut bacteria on neurological function is still developing, understanding the gut-microbiome-brain links has the potential to transform neuroscience by discovering possibly new etiologies for mental and neurodegenerative diseases. Overall, our results show that patients with diverse brain disorders have changed bacterial metabolites, as well as the possible neuroactive effects of gut-derived SCFAs, p-cresol, serotonin derivatives, and bacterial amyloids on disease onset and progression. The results of this study might lead to more understanding of the gut–brain axis and, as a response, to possible diagnostic, therapeutic, or preventative measures for brain disorders. Keywords

The study of the TLR (Toll-like receptor) family has progressed our knowledge of the intrinsic insusceptible framework. The familiar resistant of microorganisms' constitutive and protected substances is the reason for intrinsic insusceptible response. Similarly, TLRs can be blocked by damaging substances. Favorable to provocative cytokines are created when TLRs are actuated by microbial or have determined mixtures that can be valuable or unsafe to the host. TLRs are found in an assortment of organs, including those of the cardiovascular framework, notwithstanding invulnerable cells. This review takes a gander at the job of TLRs in septic cardiomyopathy, viral myocarditis, there is a lack of knowledge not only about the role of clear to the TLRs in starting and coordinating homoeostatic processes inside the heart, but also about stressed actuated TLR enactment in cardiovascular framework tissues. As per mounting proof, TLRs might assume a part in the pathogenesis of atherosclerosis, viral myocarditis, widened cardiomyopathy, heart allograft dismissal, and sepsis-actuated left ventricular brokenness.

Medicinal plants are used as fundamental and low-cost source for remedy of numbers of infectious and metabolic diseases in developing and developed countries. Current research work was planned to evaluate the antibacterial, antifungal, and cytotoxic potential of hydroethanolic extract of E. grandiflorum. It was found that selected natural medicinal herb have significant (p

Antibiotic resistance is increasing at an alarming rate and is now widely recognized as a global issue that requires urgent attention. Globally, the demand for new drugs has increased due to multidrug-resistant pathogens and emerging viruses. One promising avenue of research involves antibiotic resistance breakers (ARBs), which may or may not have direct antibacterial effects and can either be co-administered with or conjugated with failing antibiotics. This strategy may increase an antibiotic’s spectrum and its efficacy against bacteria that have acquired resistance against it and reduce the dosage necessary for an antibiotic. In this chapter, we have discussed antibiotic resistance breakers, their classification, and mechanisms of action in combating microbial resistance. Moreover, this chapter will also focus on the nanotechnological approach, a novel delivery platform using nano-carriers used to overcome the permeability barrier encountered in resistant bacteria. Nano-carriers are also used to selectively deliver high concentrations of antibiotics locally, thus avoiding systemic side effects. Several strategies have been studied to deliver antibiotics such as the use of antimicrobial polymers, nanoparticles, and liposomes. The current study will help to understand how the resistance ability of bacteria can be overcome or reversed through antibiotic resistance breakers and nano-antibiotics.

Rhinoplasty is one of the most commonly performed aesthetic surgical procedures in plastic surgery. Over the past 20 years, one of the most gratifying operations performed by facial plastic surgeons remains rhinoplasty. Both surgeries and patients may feel like they are running "home" when everything is running as scheduled, but mutual sadness may also occur when the outcome is different. Many of the typical complexities can be prevented with careful attention to particular operational maneuvers with intentional actions, extra grafts, or more conservative resections during the main rhino-plastic procedure. A view of these retrospective problems may reveal typical risks that are preemptive when the procedure is performed. Due to the subjective character of the esthetic outcome, the identification of problems in cosmetic rhinoplasty is challenging. One may expect rhino-plastic patients more critical of the outcomes, but our experience as well as those of others suggest that the surgeon is more likely than the patient to be satisfied. With a subsequent medial collapse, the ULCs might become destabilized. Moreover, the new dorsal septum produced by the excision of the hump is smaller than the original native dorsum. Even if the ULCs shrink solidly to the septum, a constricted middle vault region will be created.

Health problems in the whole world are started to increase due to new viruses, with the beginning of 20th century. Wuhan coronavirus (which is also known as nCoV-2019) is one of current examples of such type of viruses. The people infected with this disease are likely to get genuinely unwell and need care on an ICU. A number of cultural and civic norms were monitored throughout this examination. Most standards follow a common logic that unquestionably follows the previously demonstrated method to system design. Indians are advised to look at the extremely comprehensive, tastefully prepared Guidelines of the Indian Society for Anesthesia. In this study our focus on the preventing to COVID-19 in OTT and ICU with its basic and necessary conditions which are required to secure the patients as well as the medicals staff. And also determine the products for health information.

Chronic Hepatitis C infection is a common worldwide disorder, caused by Hepatitis C Virus (HCV). Right around 180 million individuals are affected by Hepatitis C Virus infection globally and more than 50 million in South Asia. Ribavirin and interferon are used for many years for the treatment of HCV, direct acting agents, and combination therapy as well. The main problem with these therapies is that a lot of side effects are observed. A novel procedure is utilized for the treatment of HCV which is called nanotechnology. The major advantages of those technology are that there is no wastage of drugs and avoid the hydrolysis of drugs. Different kinds of the bearer are utilized as a part of the treatment of HCV like nanoparticles, bio-conjugation, micelle development and dendrites. Diverse sorts of Nano transporters are utilized that convey the medication stacked particles to target points and diminish symptoms. According to this description, the part of nanocomposite like a transporter for anti-hepatitis C virus vaccine, anti-hepatitis C virus deoxyribozymes, anti-HCV aptamers, anti-HCV phenolic compounds and their focused-on conveyance are talked about. Additionally, nanoparticles give a different strategy to antigen conveyance, which not just actuates distinctive components of the same framework yet, in addition, has great biocompatibility., {"references":["1.\tSchaefer EA, Chung RT. Anti− Hepatitis C Virus Drugs in Development. Gastroenterology. 2012 May 1;142(6):1340-50.","2.\tShepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet infectious diseases. 2005 Sep 1;5(9):558-67.","3.\tBlach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The lancet Gastroenterology & hepatology. 2017 Mar 1;2(3):161-76.","4.\tPetruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World journal of gastroenterology. 2016 Sep 9;22(34):7824.","5.\tMcEwan P, Ward T, Webster S, Kalsekar A, Brenner M, Yuan Y. Modeling the cost-effectiveness of the all oral, direct-acting antiviral regimen daclatasvir plus sofosbuvir in patients co-infected with hepatitis C virus (HCV) and HIV. Value in Health. 2015 Nov 1;18(7):A628..","6.\tFonseca-Coronado S, Escobar-Gutiérrez A, Ruiz-Tovar K, Cruz-Rivera MY, Rivera-Osorio P, Vazquez-Pichardo M, Carpio-Pedroza JC, Ruíz-Pacheco JA, Cazares F, Vaughan G. Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naive infected individuals. Journal of clinical microbiology. 2012 Feb;50(2):281-7.","7.\tMukherjee P, Bhattacharya R, Bone N, Lee YK, Patra CR, Wang S, Lu L, Secreto C, Banerjee PC, Yaszemski MJ, Kay NE. Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis. Journal of nanobiotechnology. 2007 Dec;5(1):1-3","8.\tSingh S, Pandey VK, Tewari RP, Agarwal V. Nanoparticle based drug delivery system: advantages and applications. Indian J Sci Technol. 2011 Mar;4(3):177-80.","9.\tPetros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nature reviews Drug discovery. 2010 Aug;9(8):615-27.","10.\tPillai V, Lee WM, Thiele DL, Karandikar NJ. Clinical responders to antiviral therapy of chronic HCV infection show elevated antiviral CD4+ and CD8+ T‐cell responses. Journal of viral hepatitis. 2007 May;14(5):318-29.","11.\tKamal SM, El Tawil AA, Nakano T, He Q, Rasenack J, Hakam SA, Saleh WA, Ismail A, Aziz AA, Madwar MA. Peginterferon α-2b and ribavirin therapy in chronic hepatitis C genotype 4: impact of treatment duration and viral kinetics on sustained virological response. Gut. 2005 Jun 1;54(6):858-66.","12.\tLoustaud-Ratti V, Debette-Gratien M, Jacques J, Alain S, Marquet P, Sautereau D, Rousseau A, Carrier P. Ribavirin: Past, present and future. World journal of hepatology. 2016 Jan 18;8(2):123.","13.\tChampion JA, Mitragotri S. Role of target geometry in phagocytosis. Proceedings of the National Academy of Sciences. 2006 Mar 28;103(13):4930-4.","14.\tKumar A, Ma H, Zhang X, Huang K, Jin S, Liu J, Wei T, Cao W, Zou G, Liang XJ. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials. 2012 Feb 1;33(4):1180-9.","15.\tLow PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Accounts of chemical research. 2008 Jan 15;41(1):120-9.","16.\tSaito G, Swanson JA, Lee KD. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Advanced drug delivery reviews. 2003 Feb 10;55(2):199-215.","17.\tSinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Molecular cancer therapeutics. 2006 Aug;5(8):1909-17.","18.\tGabizon A, Shmeeda H, Horowitz AT, Zalipsky S. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugates. Advanced drug delivery reviews. 2004 Apr 29;56(8):1177-92.","19.\tMisra R, Sahoo SK. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. European Journal of Pharmaceutical Sciences. 2010 Jan 31;39(1-3):152-63.","20.\tÇağdaş M, Sezer AD, Bucak S. Liposomes as potential drug carrier systems for drug delivery. Application of nanotechnology in drug delivery. 2014 Jul 25;1:1-50.","21.\tYang S, Yuan W, Jin T. Formulating protein therapeutics into particulate forms. Expert Opinion on Drug Delivery. 2009 Oct 1;6(10):1123-33.","22.\tClark AJ, Davis ME. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Proceedings of the National Academy of Sciences. 2015 Oct 6;112(40):12486-91.","23.\tParker WB. Metabolism and antiviral activity of ribavirin. Virus research. 2005 Feb 1;107(2):165-71.","24.\tJyothi KR, Beloor J, Jo A, Nguyen MN, Choi TG, Kim JH, Akter S, Lee SK, Maeng CH, Baik HH, Kang I. Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication. International Journal of Nanomedicine. 2015;10:903.","25.\tBobardt MD, Cheng G, de Witte L, Selvarajah S, Chatterji U, Sanders-Beer BE, Geijtenbeek TB, Chisari FV, Gallay PA. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus. Proceedings of the National Academy of Sciences. 2008 Apr 8;105(14):5525-30.","26.\tLakshminarayanan A, Reddy BU, Raghav N, Ravi VK, Kumar A, Maiti PK, Sood AK, Jayaraman N, Das S. A galactose-functionalized dendritic siRNA-nanovector to potentiate hepatitis C inhibition in liver cells. Nanoscale. 2015;7(40):16921-31.","27.\tYang JA, Park K, Jung H, Kim H, Hong SW, Yoon SK, Hahn SK. Target specific hyaluronic acid–interferon alpha conjugate for the treatment of hepatitis C virus infection. Biomaterials. 2011 Nov 1;32(33):8722-9.","28.\tTorrecilla J, del Pozo-Rodríguez A, Apaolaza PS, Solinís MÁ, Rodríguez-Gascón A. Solid lipid nanoparticles as non-viral vector for the treatment of chronic hepatitis C by RNA interference. International journal of pharmaceutics. 2015 Feb 1;479(1):181-8.","29.\tHang X, Peng H, Song H, Qi Z, Miao X, Xu W. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro. Journal of virological methods. 2015 Sep 15;222:150-7.","30.\tRyoo SR, Jang H, Kim KS, Lee B, Kim KB, Kim YK, Yeo WS, Lee Y, Kim DE, Min DH. Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. Biomaterials. 2012 Mar 1;33(9):2754-61.","31.\tRipoli M, Angelico R, Sacco P, Ceglie A, Mangia A. Phytoliposome-based silibinin delivery system as a promising strategy to prevent hepatitis C virus infection. Journal of biomedical nanotechnology. 2016 Apr 1;12(4):770-80.","32.\tDore GJ, Lawitz E, Hézode C, Shafran SD, Ramji A, Tatum HA, Taliani G, Tran A, Brunetto MR, Zaltron S, Strasser SI. Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection. Gastroenterology. 2015 Feb 1;148(2):355-66.","33.\tWagoner J, Negash A, Kane OJ, Martinez LE, Nahmias Y, Bourne N, Owen DM, Grove J, Brimacombe C, McKeating JA, Pécheur EI. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology. 2010 Jun;51(6):1912-21.","34.\tMin DH, Kim DE. Suppression of hepatitis C viral genome replication with RNA-cleaving deoxyribozyme. InFrom nucleic acids sequences to molecular medicine 2012 (pp. 429-452). Springer, Berlin, Heidelberg.","35.\tMaeda H, Nakamura H, Fang J. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Advanced drug delivery reviews. 2013 Jan 1;65(1):71-9.","36.\tLuke JM, Simon GG, Söderholm J, Errett JS, August JT, Gale Jr M, Hodgson CP, Williams JA. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. Journal of virology. 2011 Feb 1;85(3):1370-83.","37.\tPan Q, Tilanus HW, Janssen HL, van der Laan LJ. Prospects of RNAi and microRNA-based therapies for hepatitis C. Expert opinion on biological therapy. 2009 Jun 1;9(6):713-24.","38.\tPrabhu R, Garry RF, Dash S. RETRACTED ARTICLE: Small interfering RNA targeted to stem-loop II of the 5'untranslated region effectively inhibits expression of six HCV genotypes. Virology Journal. 2006 Dec;3(1):1-1.","39.\tDykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: recent advances and perspectives. Chemical Society Reviews. 2012;41(6):2256-82.","40.\tKim M, Shin D, Kim SI, Park M. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model. Virus research. 2006 Dec 1;122(1-2):1-0.","41.\tKannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer‐based nanomedicine: from design principles to clinical applications. Journal of internal medicine. 2014 Dec;276(6):579-617.","42.\tWu J, Kamaly N, Shi J, Zhao L, Xiao Z, Hollett G, John R, Ray S, Xu X, Zhang X, Kantoff PW. Development of multinuclear polymeric nanoparticles as robust protein nanocarriers. Angewandte Chemie International Edition. 2014 Aug 18;53(34):8975-9.","43.\tZender L, Hütker S, Liedtke C, Tillmann HL, Zender S, Mundt B, Waltemathe M, Gösling T, Flemming P, Malek NP, Trautwein C. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proceedings of the National Academy of Sciences. 2003 Jun 24;100(13):7797-802.","44.\tKamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chemical reviews. 2016 Feb 24;116(4):2602-63.","45.\tZekri AR, Bahnassy AA, El-Din HM, Salama HM. Consensus siRNA for inhibition of HCV genotype-4 replication. Virology Journal. 2009 Dec;6(1):1-9.","46.\tWong PT, Choi SK. Mechanisms of drug release in nanotherapeutic delivery systems. Chemical reviews. 2015 May 13;115(9):3388-432.","47.\tZhang S, Gao H, Bao G. Physical principles of nanoparticle cellular endocytosis. ACS nano. 2015 Sep 22;9(9):8655-71.","48.\tHubbell JA, Langer R. Translating materials design to the clinic. Nature materials. 2013 Nov;12(11):963-6.","49.\tElberry MH, Darwish NH, Mousa SA. Hepatitis C virus management: potential impact of nanotechnology. Virology Journal. 2017 Dec;14(1):1-0.","50.\tCanu IG, Schulte PA, Riediker M, Fatkhutdinova L, Bergamaschi E. Methodological, political and legal issues in the assessment of the effects of nanotechnology on human health. J Epidemiol Community Health. 2018 Feb 1;72(2):148-53.","51.\tIshihara T, Kaneko K, Ishihara T, Mizushima T. Development of biodegradable nanoparticles for liver-specific ribavirin delivery. Journal of pharmaceutical sciences. 2014 Dec 1;103(12):4005-11.","52.\tOchekpe NA, Olorunfemi PO, Ngwuluka NC. Nanotechnology and drug delivery part 2: nanostructures for drug delivery. Tropical Journal of Pharmaceutical Research. 2009;8(3)."]}

Obesity have negative effects on the fertility of males and females. In females the obesity can induce hormonal imbalances for example adipokines (leptin, adiponectin, resistin, visfatin, omentin, chemerin) on reproductive axis, irregularities in menstrual cycle, reduce conception rate and complications in pregnancy. The adverse effect is insulin resistance and insulin excess that is associated with PCOS (polycystic ovary syndrome)-irregular periods. In males the obesity affects HPG gland that in turn disturb the endocrine regulation of reproductive function with high level of estrogen and low level of testosterone, progesterone, and SHBG (sex-hormone binding globulin). DNA damage of sperm, high scrotal temperature because of highly fatted scrotum area, low production of sperms and decreased motility of sperm are all the effects of obesity in males that cause infertility. The aim of the review article is to thoroughly cover the effect of obesity on reproductive functions, hormonal concentrations & fertility potential in females & males.

In modern years, there has been a large dealing of work toward the area of free radical chemistry. Free radicals reactive oxygen species and reactive nitrogen species are create by our body by various endogenic systems, influence to different physio chemical conditions or unhealthy states. A balance between free radicals and antioxidants is necessary for proper physiological function. If free radicals overwhelm the body's ability to modulate them, a condition known as oxidative stress ensues. Free radicals thus unfavorable alter lipids, proteins, and DNA and activate a number of human diseases. Hence application of external source of antioxidants can assist in coping this oxidative stress. Synthetic antioxidants such as butylated hydroxytoluene and butylated hydroxyanisole have recently been reported to be dangerous for human health. The present review provides a brief overview on oxidative stress mediate cellular damages and role of dietary antioxidants as functional foods in the organization of human diseases. We need to take balance diet which provide much more antioxidants to lower risks of health and run to life longer.The purpose of this review is that we want awareness related to sources of antioxidants from plants and highlight the studies of antioxidants and free radicals which provide prove for maintaining healthy aging. Key words: antioxidant, free radicals, aging, oxidative stress. Graphically Abstract

Fasting is a part of many world religions and in Islam fasting is obligatory for every adult Muslim during the month of Ramadan. Islam has exempted sick people from fasting; however, many people still partake in this activity. We investigated how Islamic fasting affects patients with heart failure with preserved ejection fraction (HFpEF). We enrolled 938 patients (fasting n = 456; non-fasting = 482) in this prospective observational study. The fasting group showed a decrease in NYHA functional class III (23.36% vs. 17.77%; p-value0.05) and IV (3.76% vs. 2.19%; p-value0.05), and an increase in class I(35.57% vs. 43.64%; p-value0.05). symptoms. This is an important area for physicians to advise patients with HFpEF to fast in the month of Ramadan as it can have a favorable effect on their symptoms and quality of life.

The structural, electronic, optical, and mechanical characteristics of cubic inorganic perovskites XZrO3 (X = Rb and K) were studied using the Cambridge serial total energy package-based DFT.

Technology affects almost every aspect of life and is constantly changing. Digital communication technology has made it easier and faster to connect people all over the world. Digital technology is used in varies fields, including business, industries, companies, and educational institutions. There are various benefits of technology; it is also associated with a number of risks and dangerous threats known as cybercrimes. Cybercrime is a criminal activity that targets digital technology, like a computer, a computer network, or a mobile device. Cybersecurity is the way we reduce the risk of becoming a victim of cybercrime. Cybersecurity is the process of defending against cyberattacks. By using these concepts, we investigated the interval-valued complex T-spherical fuzzy relations (IVCT-spherical-FRs) introduced in this paper. We studied the relationships between different types of cybersecurity and the sources of cyberattacks. Furthermore, the Hasse diagram for the interval-valued complex T-spherical partial order set and relation is developed. The concepts of Hasse diagram are being used to examine various cybersecurity techniques and practices. The most effective method is identified using the features of Hasse diagrams. Finally, comparison tests are used to demonstrate the benefits of the proposed methods.

Background: Counseling regarding conceiving and contraception in post renal transplant female recipients is neglected and important aspect of post-transplant care. Aim: To conduct to report use of contraceptive measures, pregnancy and its outcomes during post-transplant period. This study highlights the importance of contraceptive counseling after renal transplant. Results: Out of total 14 patients of our study only 5 (36%) were using contraception while 9 (64%) were not using any contraceptive method. Out of 9 non users 7 patients were never counseled regarding contraception. Moreover they had no awareness regarding drug modification or renal and feto-maternal outcomes of pregnancy after renal transplant. Conclusion: Reproductive age female patients undergoing renal transplant should be given special attention regarding counselling on contraception, pregnancy and it outcomes. Key words: Contraception, renal transplant, pregnancy

Background: Phytomedicine is becoming more acceptable as an alternative medicinal approach in the modern era.Objectives: The current study examined the antioxidant capacity and in vitro response of phytochemical constituents of Withania somnifera (Ashwagandha) on standard parameters of healthy volunteer semen.Methods: The phytochemicals and their pharmacological response in a hydroethanolic (30:70 v/v) extract of W. somnifera roots were determined using standard protocols.Results: The constituents included flavonoids, phenolic acids, alkaloids, and terpenoids were reported. High-performance liquid chromatography and Fourier-transform infrared spectroscopy determined a diverse array of biologically active chemical constituents in the extract. The extract of W. somnifera exhibits substantial antioxidant properties, including total antioxidant capacity, 2,2-diphenyl-1-picrylhydrazyl inhibition, H2O2 scavenging, and Fe3+ reducing potential ( P < .05). The analysis of essential natural minerals explored adequate levels determined using atomic absorption spectrophotometer. Cytotoxic studies revealed significant thrombolytic, RBC membrane stabilization, and DNA damage protection activity ( P < .05) while remaining non-mutagenic against Salmonella typhi TA98 and TA100. The best protective response of W. somnifera extract on human semen parameters (n = 30), such as total motility, progressive motility, and viability, demonstrated a significant ( P < .05) improvement, particularly at the dose of 25 μg/mL and 50 μg/mL.Conclusion: The study concludes that W. somnifera possesses favorable in vitro characteristics that could aid in the preservation of sperm during intrauterine insemination and in vitro fertilization.